[A14-10] Addendum to Commission A13-35 (dabrafenib)
Last updated 03.04.2014
Project no.:
A14-10
Commission:
Commission awarded on 04.03.2014 by the Federal Joint Committee (G-BA).
Report type:
Addendum
Status:
Commission completed
Department/Division:
Drug Assessment
Topic:
Skin and hair
Note:
If the need for additional work on a project commissioned by the G-BA arises during consultations, then IQWiG presents a report in the form of an "addendum". The G-BA subsequently decides on the extent of the added benefit, thus completing the early benefit assessment
| Project no. | Title | Status |
|---|---|---|
| A13-35 | Dabrafenib - Benefit assessment according to § 35a Social Code Book V (dossier assessment) | Commission completed |
Federal Joint Committee (G-BA)
2014-04-03 A G-BA decision was published.